Medpace Holdings (MEDP) Is Up 6.3% After Q4 Revenue Beats Peers And Analyst Forecasts Has The Bull Case Changed? [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
3.3% and delivered the strongest growth and estimate beats among its drug development services peers. The company's choice to reinvest earnings rather than pay dividends, alongside its sector-leading revenue expansion and earnings outperformance, highlights a business model geared towards funding future growth in clinical research services. With Medpace's Q4 revenue climbing 32% and outpacing analyst forecasts, we'll examine how this performance influences its investment narrative. Find 47 companies with promising cash flow potential yet trading below their fair value Medpace Holdings Investment Narrative Recap To own Medpace, you need to believe that demand for outsourced clinical trials will stay solid enough to support its reinvestment-heavy model and high returns on capital. The key short term catalyst is whether recent backlog and bookings trends can convert into sustained revenue growth, while the biggest risk is that fragile biotech funding and rising competition coul
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (MEDP) was upgraded by Royal Bank Of Canada to "moderate buy".MarketBeat
- Medpace (MEDP) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $522.00 price target on the stock.MarketBeat
- Evaluating Medpace Holdings (MEDP) After A Sharp 27% One-Month Pullback [Yahoo! Finance]Yahoo! Finance
- Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
MEDP
Earnings
- 2/9/26 - Beat
MEDP
Sec Filings
- 2/18/26 - Form 4
- 2/17/26 - Form 4
- 2/17/26 - Form 4
- MEDP's page on the SEC website